Literature DB >> 2993658

Proteins associated with human parainfluenza virus type 3.

R C Jambou, N Elango, S Venkatesan.   

Abstract

The polypeptides associated with human parainfluenza virus type 3 were identified. Five proteins were present in detergent- and salt-resistant viral cores. Of these, three proteins designated NP0, NP1, and NP2 of 68,000, 58,000, and 52,000 daltons, respectively, were stably associated with 50S RNA in CsCl gradient-purified nucleocapsids. The amounts of NP1 and NP2 were variable, and these proteins were shown to be structurally related to the major nucleocapsid protein (NP0) by partial Staphylococcus aureus V8 protease mapping. The other core proteins included a 240K protein designated L (candidate for the viral polymerase) and an 84K protein designated as the phosphoprotein (P) on the basis of a predominant incorporation of Pi. The viral envelope had four prominent proteins (72, 53, 40, and 12K) under reducing conditions of electrophoresis. The 72 and 53K proteins were specifically labeled with [3H]glucosamine and [3H]mannose. When sulfhydryl reagents were removed, a new 62K protein was visualized in place of the 72, 53, and 12K proteins. The 53 and 12K proteins were interpreted to be the two subunits (F1 and F2) of the fusion protein, and the 72K protein was designated as the HN (hemagglutinin-neuraminidase) glycoprotein. The unglycosylated 40K protein represented the viral matrix protein (M). Immunoprecipitation of infected cell lysates with rabbit hyperimmune antiserum against purified virus confirmed the viral origin of these polypeptides.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2993658      PMCID: PMC252530     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  27 in total

1.  Acute respiratory diseases of viral etiology. III. parainfluenza. Myxoviruses.

Authors:  R H PARROTT; A J VARGOSKO; J A BELL; R M CHANOCK
Journal:  Am J Public Health Nations Health       Date:  1962-06

2.  Protease activation mutants of sendai virus. Activation of biological properties by specific proteases.

Authors:  A Scheid; P W Choppin
Journal:  Virology       Date:  1976-01       Impact factor: 3.616

3.  Two disulfide-linked polypeptide chains constitute the active F protein of paramyxoviruses.

Authors:  A Scheid; P W Choppin
Journal:  Virology       Date:  1977-07-01       Impact factor: 3.616

4.  Determination by peptide mapping of the unique polypeptides in Sendai virions and infected cells.

Authors:  R A Lamb; P W Choppin
Journal:  Virology       Date:  1978-02       Impact factor: 3.616

5.  Identification of biological activities of paramyxovirus glycoproteins. Activation of cell fusion, hemolysis, and infectivity of proteolytic cleavage of an inactive precursor protein of Sendai virus.

Authors:  A Scheid; P W Choppin
Journal:  Virology       Date:  1974-02       Impact factor: 3.616

6.  Structural characterization of virion proteins and genomic RNA of human parainfluenza virus 3.

Authors:  D G Storey; K Dimock; C Y Kang
Journal:  J Virol       Date:  1984-12       Impact factor: 5.103

7.  A comparison of paramyxoviruses by immunoprecipitation.

Authors:  K K Goswami; W C Russell
Journal:  J Gen Virol       Date:  1982-05       Impact factor: 3.891

8.  Functions of Sendai virus nucleocapsid polypeptides: enzymatic activities in nucleocapsids following cleavage of polypeptide P by Staphylococcus aureus protease V8.

Authors:  V G Chinchar; A Portner
Journal:  Virology       Date:  1981-02       Impact factor: 3.616

9.  In vitro synthesis of structural and nonstructural proteins of Sendai and SV5 viruses.

Authors:  P R Etkind; R K Cross; R A Lamb; D C Merz; P W Choppin
Journal:  Virology       Date:  1980-01-15       Impact factor: 3.616

10.  Association of a new type of cytopathogenic myxovirus with infantile croup.

Authors:  R M CHANOCK
Journal:  J Exp Med       Date:  1956-10-01       Impact factor: 14.307

View more
  9 in total

1.  Expression of the F and HN glycoproteins of human parainfluenza virus type 3 by recombinant vaccinia viruses: contributions of the individual proteins to host immunity.

Authors:  M K Spriggs; B R Murphy; G A Prince; R A Olmsted; P L Collins
Journal:  J Virol       Date:  1987-11       Impact factor: 5.103

2.  Conserved epitopes on the hemagglutinin-neuraminidase proteins of human and bovine parainfluenza type 3 viruses: nucleotide sequence analysis of variants selected with monoclonal antibodies.

Authors:  K J Coelingh; C C Winter; B R Murphy; J M Rice; P C Kimball; R A Olmsted; P L Collins
Journal:  J Virol       Date:  1986-10       Impact factor: 5.103

3.  Characterization of an in vitro system for the synthesis of mRNA from human parainfluenza virus type 3.

Authors:  B P De; M S Galinski; A K Banerjee
Journal:  J Virol       Date:  1990-03       Impact factor: 5.103

4.  The polypeptides of human parainfluenza type 2 virus and their synthesis in infected cells.

Authors:  Y Ito; M Tsurudome; M Hishiyama
Journal:  Arch Virol       Date:  1987       Impact factor: 2.574

5.  Human parainfluenza type 3 virus hemagglutinin-neuraminidase glycoprotein: nucleotide sequence of mRNA and limited amino acid sequence of the purified protein.

Authors:  N Elango; J E Coligan; R C Jambou; S Venkatesan
Journal:  J Virol       Date:  1986-02       Impact factor: 5.103

6.  Human parainfluenza virus type 3: messenger RNAs, polypeptide coding assignments, intergenic sequences, and genetic map.

Authors:  M K Spriggs; P L Collins
Journal:  J Virol       Date:  1986-09       Impact factor: 5.103

7.  Functional interaction of paramyxovirus glycoproteins: identification of a domain in Sendai virus HN which promotes cell fusion.

Authors:  K Tanabayashi; R W Compans
Journal:  J Virol       Date:  1996-09       Impact factor: 5.103

Review 8.  Parainfluenza viruses.

Authors:  Kelly J Henrickson
Journal:  Clin Microbiol Rev       Date:  2003-04       Impact factor: 26.132

9.  Human parainfluenza virus type 3 transcription in vitro: role of cellular actin in mRNA synthesis.

Authors:  B P De; A Lesoon; A K Banerjee
Journal:  J Virol       Date:  1991-06       Impact factor: 5.103

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.